Magar, S. D. and Pawar, P. Y. (2022) “In silico ADMET screening & molecular docking of some 1-(5-(4-chlorophenyl)-1,3,4-oxadiazol-3(2H)-yl) ethanone derivatives to be developed as triple mutant T790M/C797S EGFR inhibitors”, International journal of health sciences, 6(S3), pp. 10432–10451. doi: 10.53730/ijhs.v6nS3.9448.